{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:24:12Z","timestamp":1791923052281,"version":"4.3.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s11764-022-01279-9","type":"journal-article","created":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T06:05:11Z","timestamp":1670997911000},"page":"761-771","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Development of a disease conceptual model of patient experience with metastatic colorectal cancer: identification of the most salient symptoms and impacts"],"prefix":"10.1007","volume":"18","author":[{"given":"Isabelle","family":"Guillemin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh","family":"Darpelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendon","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Ingelg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingolf","family":"Griebsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,14]]},"reference":[{"issue":"6","key":"1279_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"1279_CR2","doi-asserted-by":"publisher","first-page":"184","DOI":"10.14740\/gr1167","volume":"13","author":"E Levin-Sparenberg","year":"2020","unstructured":"Levin-Sparenberg E, Bylsma LC, Lowe K, Sangare L, Fryzek JP, Alexander DD. A systematic literature review and meta-analysis describing the prevalence of KRAS, NRAS, and BRAF gene mutations in metastatic colorectal cancer. Gastroenterol Res. 2020;13(5):184\u201398.","journal-title":"Gastroenterol Res"},{"key":"1279_CR3","unstructured":"Surveillance, epidemiology, and end results program [Internet]. SEER. Available from: https:\/\/seer.cancer.gov\/index.html.\u00a0Accessed 19 July 2022."},{"key":"1279_CR4","first-page":"djac158","volume":"22","author":"L Gallicchio","year":"2022","unstructured":"Gallicchio L, Devasia TP, Tonorezos E, Mollica MA, Mariotto A. Estimation of the number of individuals living with metastatic cancer in the United States. JNCI J Natl Cancer Inst. 2022;22:djac158.","journal-title":"JNCI J Natl Cancer Inst."},{"issue":"7","key":"1279_CR5","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/jama.2021.0106","volume":"325","author":"LH Biller","year":"2021","unstructured":"Biller LH, Schrag D. Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA. 2021;325(7):669\u201385.","journal-title":"JAMA"},{"key":"1279_CR6","doi-asserted-by":"crossref","unstructured":"Carduff E, Kendall M, Murray SA. Living and dying with metastatic bowel cancer: serial in-depth interviews with patients. Eur J Cancer Care (Engl). 2018;27(1):e12653.","DOI":"10.1111\/ecc.12653"},{"issue":"11","key":"1279_CR7","first-page":"954","volume":"17","author":"DP Harji","year":"2015","unstructured":"Harji DP, Koh C, Solomon M, Velikova G, Sagar PM, Brown J. Development of a conceptual framework of health-related quality of life in locally recurrent rectal cancer. Colorectal Dis Off J Assoc Coloproctology G B Irel. 2015;17(11):954\u201364.","journal-title":"Colorectal Dis Off J Assoc Coloproctology G B Irel"},{"issue":"1","key":"1279_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ecc.12271","volume":"25","author":"DV Oberoi","year":"2016","unstructured":"Oberoi DV, Jiwa M, McManus A, Hodder R, de Nooijer J. Help-seeking experiences of men diagnosed with colorectal cancer: a qualitative study. Eur J Cancer Care (Engl). 2016;25(1):27\u201337.","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"5","key":"1279_CR9","first-page":"2017","volume":"24","author":"CE Mosher","year":"2016","unstructured":"Mosher CE, Adams RN, Helft PR, O\u2019Neil BH, Shahda S, Rattray NA, et al. Family caregiving challenges in advanced colorectal cancer: patient and caregiver perspectives. Support Care Cancer Off J Multinatl Assoc Support Care Cancer. 2016;24(5):2017\u201324.","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"issue":"11","key":"1279_CR10","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1016\/j.clinthera.2017.09.015","volume":"39","author":"J Gong","year":"2017","unstructured":"Gong J, Wu D, Chuang J, Tuli R, Simard J, Hendifar A. Moving beyond conventional clinical trial end points in treatment-refractory metastatic colorectal cancer: a composite quality-of-life and symptom control end point. Clin Ther. 2017;39(11):2135\u201345.","journal-title":"Clin Ther"},{"key":"1279_CR11","unstructured":"Patient-focused drug development guidance: methods to identify what is important to patients and select, develop or modify fit-for-purpose clinical outcome assessments [Internet]. U.S. Food and Drug Administration. 2019. Available from:\u00a0https:\/\/www.fda.gov\/drugs\/news-events-human-drugs\/patient-focused-drug-development-guidance-methods-identify-what-important-patients-and-select.\u00a0Accessed 19 July 2022."},{"issue":"1","key":"1279_CR12","doi-asserted-by":"publisher","first-page":"160940691770298","DOI":"10.1177\/1609406917702983","volume":"16","author":"KKF Cheng","year":"2017","unstructured":"Cheng KKF, Clark AM. Qualitative methods and patient-reported outcomes: measures development and adaptation. Int J Qual Methods. 2017;16(1):160940691770298.","journal-title":"Int J Qual Methods"},{"issue":"8","key":"1279_CR13","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.jval.2011.06.014","volume":"14","author":"DL Patrick","year":"2011","unstructured":"Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, et al. Content validity\u2013establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1\u2013eliciting concepts for a new PRO instrument. Value Health J Int Soc Pharmacoeconomics Outcomes Res. 2011;14(8):967\u201377.","journal-title":"Value Health J Int Soc Pharmacoeconomics Outcomes Res"},{"issue":"7","key":"1279_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0199423","volume":"13","author":"CE Atreya","year":"2018","unstructured":"Atreya CE, Kubo A, Borno HT, Rosenthal B, Campanella M, Rettger JP, et al. Being Present: A single-arm feasibility study of audio-based mindfulness meditation for colorectal cancer patients and caregivers. PLoS ONE. 2018;13(7): e0199423.","journal-title":"PLoS ONE"},{"issue":"4","key":"1279_CR15","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1081\/CNV-120022366","volume":"21","author":"D Cella","year":"2003","unstructured":"Cella D, Paul D, Yount S, Winn R, Chang CH, Banik D, et al. What are the most important symptom targets when treating advanced cancer? A survey of providers in the National Comprehensive Cancer Network (NCCN). Cancer Invest. 2003;21(4):526\u201335.","journal-title":"Cancer Invest"},{"issue":"5","key":"1279_CR16","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/09540261.2017.1288090","volume":"29","author":"R Caruso","year":"2017","unstructured":"Caruso R, Nanni MG, Riba MB, Sabato S, Grassi L. The burden of psychosocial morbidity related to cancer: patient and family issues. Int Rev Psychiatry Abingdon Engl. 2017;29(5):389\u2013402.","journal-title":"Int Rev Psychiatry Abingdon Engl"},{"issue":"1","key":"1279_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/00002820-199902000-00012","volume":"22","author":"P Yates","year":"1999","unstructured":"Yates P. Family coping: issues and challenges for cancer nursing. Cancer Nurs. 1999;22(1):63\u201371.","journal-title":"Cancer Nurs"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-022-01279-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11764-022-01279-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-022-01279-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T10:40:21Z","timestamp":1744195221000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11764-022-01279-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,14]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1279"],"URL":"https:\/\/doi.org\/10.1007\/s11764-022-01279-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1917523\/v1","asserted-by":"object"}]},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"value":"1932-2259","type":"print"},{"value":"1932-2267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,14]]},"assertion":[{"value":"1 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice and applicable regulatory requirements. The study and all interview materials received Independent Review Board (IRB) approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Isabelle Guillemin and Mahesh Darpelly are employees of IQVIA. IQVIA conducted the study analyses. IQVIA were paid consultants to Boehringer Ingelheim in connection with the development of this manuscript. Brendon Wong, Anders Ingelg\u00e5rd and Ingolf Griebsch are employees of Boehringer Ingelheim. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials of the study apart from those disclosed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}